Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
Abstract The repeat emergence of SARS-CoV-2 variants of concern (VoC) with decreased susceptibility to vaccine-elicited antibodies highlights the need to develop next-generation vaccine candidates that confer broad protection. Here we describe the antibody response induced by the SARS-CoV-2 Spike Fe...
Similar Items
-
Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity
by: Wei-Hung Chen, et al.
Published: (2023-02-01) -
Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamsters
by: Hannah A. D. King, et al.
Published: (2023-03-01) -
Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development
by: Vincent Dussupt, et al.
Published: (2021-02-01) -
Correlation of membrane binding and hydrophobicity to the chaperone-like activity of PDC-109, the major protein of bovine seminal plasma.
by: Rajeshwer S Sankhala, et al.
Published: (2011-01-01) -
Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in <i>E. coli</i> Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched Variants
by: Arasu Balasubramaniyam, et al.
Published: (2022-12-01)